BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2003
View Archived Issues
Neose to develop glycoPEGylated G-CSF
Read More
Dual role of adenosine A2A receptor activation in wound healing
Read More
CytRx licenses copolymer technologies to SynthRx
Read More
Evotec and Roche enter medicinal chemistry collaboration in oncology
Read More
SBIR grant supports development of modified annexin V
Read More
A novel therapeutic role suggested for vitamin D analogues in breast cancer
Read More
PEG-sTNF-RI reported effective in improving the symptoms of rheumatoid arthritis
Read More
Good safety profile reported for i.v. LJP-1082 in antiphospholipid syndrome
Read More
Potential use of pioglitazone in the treatment of psoriatic arthritis
Read More
Beneficial effects described for OPC-28326 in Raynaud's phenomenon
Read More
Improved tear production on topical ciclosporin in Sjogren's syndrome
Read More
Antiarthritic effects of atlizumab in different patient populations
Read More
Betagenon and AstraZeneca team up to tackle type 2 diabetes
Read More
Febuxostat in the treatment of gout and hyperuricemia
Read More
New TPO receptor agonists and their use as antithrombocytopenic agents
Read More
Synthetic discorhabdin analogues and intermediates covered by Sankyo patent
Read More
Novel HDAC inhibitors isolated from a marine sponge by Yamanouchi scientists
Read More
Steryl sulfatase inhibitors identified by Kyowa Hakko researchers
Read More
Sumitomo reports the discovery and testing of naturally produced neuroprotectants
Read More
Novel gluconeogenesis inhibitors under study at Sumitomo
Read More
Yamanouchi describes new antitumor agents from Pseudomonas species
Read More
Bay-43-9006 enters pivotal phase III trial in kidney cancer
Read More
Cyberonics submits PMA-S for VNS Therapy
Read More
EN-3247 fails to prevent oral mucositis in pivotal trial
Read More
Remicade reduces signs and symptoms of anklyosing spondylitis in ASSERT trial
Read More
Phase I IND cleared for T-62
Read More
Daivobet effective in severe psoriasis
Read More
Extended phase II data show RA patients benefit from MabThera for up to 48 weeks
Read More